Selected research
Industry Growth & Trends
Global Soluble Epoxide Hydrolase Industry Growth and Trends Forecast to 2032
Market perspective
The global Soluble Epoxide Hydrolase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Soluble Epoxide Hydrolase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Soluble Epoxide Hydrolase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Soluble Epoxide Hydrolase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Soluble Epoxide Hydrolase include GlaxoSmithKline Plc, Toray Industries, Inc., Sumitomo Dainippon Pharma Co., Ltd. and Sphaera Pharma Pvt. Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Soluble Epoxide Hydrolase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Soluble Epoxide Hydrolase market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Soluble Epoxide Hydrolase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Soluble Epoxide Hydrolase.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Soluble Epoxide Hydrolase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Soluble Epoxide Hydrolase Market by Company
GlaxoSmithKline Plc
Toray Industries, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Sphaera Pharma Pvt. Ltd.
Soluble Epoxide Hydrolase Segment by Type
GSK-2256294
EC-5026
Others
Soluble Epoxide Hydrolase Segment by Application
Hospital
Clinic
Others
Soluble Epoxide Hydrolase Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soluble Epoxide Hydrolase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Soluble Epoxide Hydrolase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soluble Epoxide Hydrolase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soluble Epoxide Hydrolase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Soluble Epoxide Hydrolase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- GSK-2256294
- EC-5026
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- GlaxoSmithKline Plc
- Toray Industries, Inc.
- Sumitomo Dainippon Pharma Co., Ltd.
- Sphaera Pharma Pvt. Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Soluble Epoxide Hydrolase Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Soluble Epoxide Hydrolase Sales Estimates and Forecasts (2021-2032)
- 1.3 Soluble Epoxide Hydrolase Market by Type
- 1.3.1 GSK-2256294
- 1.3.2 EC-5026
- 1.3.3 Others
- 1.4 Global Soluble Epoxide Hydrolase Market Size by Type
- 1.4.1 Global Soluble Epoxide Hydrolase Market Size Overview by Type (2021-2032)
- 1.4.2 Global Soluble Epoxide Hydrolase Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Soluble Epoxide Hydrolase Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Soluble Epoxide Hydrolase Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Soluble Epoxide Hydrolase Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Soluble Epoxide Hydrolase Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Soluble Epoxide Hydrolase Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Soluble Epoxide Hydrolase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Soluble Epoxide Hydrolase Industry Trends
- 2.2 Soluble Epoxide Hydrolase Industry Drivers
- 2.3 Soluble Epoxide Hydrolase Industry Opportunities and Challenges
- 2.4 Soluble Epoxide Hydrolase Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Soluble Epoxide Hydrolase Revenue (2021-2026)
- 3.2 Global Top Players by Soluble Epoxide Hydrolase Sales (2021-2026)
- 3.3 Global Top Players by Soluble Epoxide Hydrolase Price (2021-2026)
- 3.4 Global Soluble Epoxide Hydrolase Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Soluble Epoxide Hydrolase Major Company Production Sites & Headquarters
- 3.6 Global Soluble Epoxide Hydrolase Company, Product Type & Application
- 3.7 Global Soluble Epoxide Hydrolase Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Soluble Epoxide Hydrolase Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Soluble Epoxide Hydrolase Players Market Share by Revenue in 2025
- 3.8.3 2025 Soluble Epoxide Hydrolase Tier 1, Tier 2, and Tier 3
4 Soluble Epoxide Hydrolase Regional Status and Outlook
- 4.1 Global Soluble Epoxide Hydrolase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Soluble Epoxide Hydrolase Historic Market Size by Region
- 4.2.1 Global Soluble Epoxide Hydrolase Sales in Volume by Region (2021-2026)
- 4.2.2 Global Soluble Epoxide Hydrolase Sales in Value by Region (2021-2026)
- 4.2.3 Global Soluble Epoxide Hydrolase Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Soluble Epoxide Hydrolase Forecasted Market Size by Region
- 4.3.1 Global Soluble Epoxide Hydrolase Sales in Volume by Region (2027-2032)
- 4.3.2 Global Soluble Epoxide Hydrolase Sales in Value by Region (2027-2032)
- 4.3.3 Global Soluble Epoxide Hydrolase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Soluble Epoxide Hydrolase by Application
- 5.1 Soluble Epoxide Hydrolase Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Soluble Epoxide Hydrolase Market Size by Application
- 5.2.1 Global Soluble Epoxide Hydrolase Market Size Overview by Application (2021-2032)
- 5.2.2 Global Soluble Epoxide Hydrolase Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Soluble Epoxide Hydrolase Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Soluble Epoxide Hydrolase Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Soluble Epoxide Hydrolase Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Soluble Epoxide Hydrolase Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Soluble Epoxide Hydrolase Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Soluble Epoxide Hydrolase Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 GlaxoSmithKline Plc
- 6.1.1 GlaxoSmithKline Plc Company Information
- 6.1.2 GlaxoSmithKline Plc Business Overview
- 6.1.3 GlaxoSmithKline Plc Soluble Epoxide Hydrolase Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 GlaxoSmithKline Plc Soluble Epoxide Hydrolase Product Portfolio
- 6.1.5 GlaxoSmithKline Plc Recent Developments
- 6.2 Toray Industries, Inc.
- 6.2.1 Toray Industries, Inc. Company Information
- 6.2.2 Toray Industries, Inc. Business Overview
- 6.2.3 Toray Industries, Inc. Soluble Epoxide Hydrolase Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Toray Industries, Inc. Soluble Epoxide Hydrolase Product Portfolio
- 6.2.5 Toray Industries, Inc. Recent Developments
- 6.3 Sumitomo Dainippon Pharma Co., Ltd.
- 6.3.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
- 6.3.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
- 6.3.3 Sumitomo Dainippon Pharma Co., Ltd. Soluble Epoxide Hydrolase Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sumitomo Dainippon Pharma Co., Ltd. Soluble Epoxide Hydrolase Product Portfolio
- 6.3.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
- 6.4 Sphaera Pharma Pvt. Ltd.
- 6.4.1 Sphaera Pharma Pvt. Ltd. Company Information
- 6.4.2 Sphaera Pharma Pvt. Ltd. Business Overview
- 6.4.3 Sphaera Pharma Pvt. Ltd. Soluble Epoxide Hydrolase Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sphaera Pharma Pvt. Ltd. Soluble Epoxide Hydrolase Product Portfolio
- 6.4.5 Sphaera Pharma Pvt. Ltd. Recent Developments
7 North America by Country
- 7.1 North America Soluble Epoxide Hydrolase Sales by Country
- 7.1.1 North America Soluble Epoxide Hydrolase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Soluble Epoxide Hydrolase Sales by Country (2021-2026)
- 7.1.3 North America Soluble Epoxide Hydrolase Sales Forecast by Country (2027-2032)
- 7.2 North America Soluble Epoxide Hydrolase Market Size by Country
- 7.2.1 North America Soluble Epoxide Hydrolase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Soluble Epoxide Hydrolase Market Size by Country (2021-2026)
- 7.2.3 North America Soluble Epoxide Hydrolase Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Soluble Epoxide Hydrolase Sales by Country
- 8.1.1 Europe Soluble Epoxide Hydrolase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Soluble Epoxide Hydrolase Sales by Country (2021-2026)
- 8.1.3 Europe Soluble Epoxide Hydrolase Sales Forecast by Country (2027-2032)
- 8.2 Europe Soluble Epoxide Hydrolase Market Size by Country
- 8.2.1 Europe Soluble Epoxide Hydrolase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Soluble Epoxide Hydrolase Market Size by Country (2021-2026)
- 8.2.3 Europe Soluble Epoxide Hydrolase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Soluble Epoxide Hydrolase Sales by Country
- 9.1.1 Asia-Pacific Soluble Epoxide Hydrolase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Soluble Epoxide Hydrolase Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Soluble Epoxide Hydrolase Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Soluble Epoxide Hydrolase Market Size by Country
- 9.2.1 Asia-Pacific Soluble Epoxide Hydrolase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Soluble Epoxide Hydrolase Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Soluble Epoxide Hydrolase Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Soluble Epoxide Hydrolase Sales by Country
- 10.1.1 South America Soluble Epoxide Hydrolase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Soluble Epoxide Hydrolase Sales by Country (2021-2026)
- 10.1.3 South America Soluble Epoxide Hydrolase Sales Forecast by Country (2027-2032)
- 10.2 South America Soluble Epoxide Hydrolase Market Size by Country
- 10.2.1 South America Soluble Epoxide Hydrolase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Soluble Epoxide Hydrolase Market Size by Country (2021-2026)
- 10.2.3 South America Soluble Epoxide Hydrolase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Soluble Epoxide Hydrolase Sales by Country
- 11.1.1 Middle East and Africa Soluble Epoxide Hydrolase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Soluble Epoxide Hydrolase Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Soluble Epoxide Hydrolase Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Soluble Epoxide Hydrolase Market Size by Country
- 11.2.1 Middle East and Africa Soluble Epoxide Hydrolase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Soluble Epoxide Hydrolase Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Soluble Epoxide Hydrolase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Soluble Epoxide Hydrolase Value Chain Analysis
- 12.1.1 Soluble Epoxide Hydrolase Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Soluble Epoxide Hydrolase Production Mode & Process
- 12.2 Soluble Epoxide Hydrolase Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Soluble Epoxide Hydrolase Distributors
- 12.2.3 Soluble Epoxide Hydrolase Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst